de Otero J, Suriñach J M, Ribera E, Alegre J, Juste C, Río J
Unidad de Enfermedades Infecciosas, Hospital General Universitari de la Vall d'Hebron, Universidad Autónoma, Barcelona.
Enferm Infecc Microbiol Clin. 1995 Jan;13(1):6-11.
The aim of the present study was to analyze the clinical characteristics and fluid alterations in neurologic infection by varicella herpes zoster virus in hospitalized patients.
A retrospective study of the cases with neurologic involvement by the varicella herpes zoster virus in patients admitted in the authors' hospital from March 1991 to March 1993 was carried out.
Our of the 14 patients studied with neurologic involvement by the varicella herpes zoster virus, 10 were males (71%) with a mean age of 38 years (range: 13-83 years). Only 4 patients (28%) presented a base disease (diabetes mellitus in 2 cases and HIV infection in another 2). In 10 cases (71%) the appearance of cutaneous lesions was prior to neurologic manifestations (between 1 and 30 days before neurologic clinical manifestations). All the patients presented hyperthermia at some time. The most common symptoms were: headache, vomiting, confusion and/or neck stiffness, with meningitis, encephalitis and neurologic foci and mixed pictures. In 4 cases (28%) the cephalorhachidian fluid did not present analytical changes suggestive of viral meningitis. All the patients underwent i.v. acyclovir treatment at a dosis of 10-15 mg/kg/8 h with good evolution, with no deaths being observed. In 3 out of the 6 cases presenting neurologic foci the evolution was slow with sequelae following treatment completion.
Neurologic involvement by the varicella herpes zoster virus does not clinically defer from other neutrotropic virus. Fluid alterations were compatible with benign lymphocytary meningitis although some cases of encephalitis showed normal LCR. Taking into account that none of the patients herein reported died and considering the mortality associated with meningitis or encephalitis by varicella herpes zoster referred in the literature in untreated patients, the authors believe that the use of acyclovir is obligatory in these cases.
本研究旨在分析住院患者中水痘带状疱疹病毒所致神经感染的临床特征及体液变化。
对1991年3月至1993年3月在作者所在医院住院的水痘带状疱疹病毒所致神经受累患者进行回顾性研究。
在14例研究的水痘带状疱疹病毒所致神经受累患者中,10例为男性(71%),平均年龄38岁(范围:13 - 83岁)。仅4例患者(28%)有基础疾病(2例为糖尿病,另2例为HIV感染)。10例患者(71%)皮肤病变出现在神经症状之前(在神经临床表现前1至30天)。所有患者均有过发热。最常见的症状为:头痛、呕吐、意识模糊和/或颈部强直,伴有脑膜炎、脑炎及神经病灶和混合表现。4例患者(28%)脑脊液未出现提示病毒性脑膜炎的分析变化。所有患者均接受静脉注射阿昔洛韦治疗,剂量为10 - 15mg/kg/8小时,病情好转,未观察到死亡病例。6例有神经病灶的患者中,3例病情进展缓慢,治疗结束后有后遗症。
水痘带状疱疹病毒所致神经受累在临床上与其他嗜神经病毒无差异。体液变化符合良性淋巴细胞性脑膜炎,尽管部分脑炎病例脑脊液淋巴细胞计数正常。考虑到本文报道的患者均未死亡,且文献中提及未经治疗的水痘带状疱疹病毒所致脑膜炎或脑炎的死亡率,作者认为在这些病例中使用阿昔洛韦是必要的。